Including Shareholders to Your Private Practice in Oral Surgery and Dentistry: Ukrainian Laws

Dental clinic/office launch and development is non-easy task, which require not only a lot of efforts but also some level of the investments, especially for the commercial real estate and expensive equipment. And very often the amount of finances which one person or family is bringing to business may not be sufficient. Including of shareholders can help to reach that goal. Including the partners (ie, cofounders or shareholders) to your private clinic/ office in a legal form of Limited Liability Company (LLC) are possible upon two stages: (1) upon the business launch and (2) upon the business existence. The second variant is more complicated and has to be analyzed.

Usage of the Medical Product Ketanov in the Maxillofacial Surgery

Pain is the psychophysiological condition of a person arising in as a result of the action of ultra-strong or destructive irritants causing organic or functional disturbances in the organism. The purpose of our research was to evaluate analgesic efficiency of the medicinal product ketanov (ketorolac tromethamine), produced by the firm “Ranbaxy” in patients with diseases of the maxillofacial region. We monitored 127 cases, which we divided into the following groups: Group I of 44 patients after performing dental surgery (extraction of tumors and tumor-like formations of jaws and soft tissues, plastic and reconstructive operations); Group II – 23 patients with mandibular fractures; Group III – 27 patients with inflammatory diseases of the soft tissues; Group IV – 19 patients with rhythmic diseases of the maxillofacial region (odontogenic neuralgia, post-traumatic and post-operative neuralgo-neuritis); Group V – 14 patients who have undergone the surgical phase of dental implantation. Ketanov (ketorolac tromethamine) is a highly effective analgesic and is recommended for use in the post-operative period after removal of tumors and tumor-like formations of the jaws and soft tissues of the face and neck, after plastic and reconstructive operations, in case of jaw fractures, purulent inflammatory processes, odontogenic neuralgia, postoperative and post-traumatic neuralgo-neuritis of peripheral branches of the trigeminal nerve, as well as after the surgical stage of dental implantation.

Treatment of the Temporomandibular Joint Arthritis

Temporomandibular joint (TMJ) arthritis is an inflammatory process in the TMJ. It`s more common in young and middle-aged people. Among the reasons of the TMJ arthritis development may be the following: local infection (periodontal disease, gingivitis, stomatitis, otitis, tonsillitis, osteomyelitis of the jaw, etc.), general infectious diseases (acute respiratory infections, influenza, pneumonia, dysentery, tuberculosis, syphilis, etc.), allergic diseases, traumatic effects, etc. Para-allergic factors contribute to the onset of TMJ inflammatory processes (hypothermia, overheating, etc.), changes in the endocrine and nervous systems, foci of chronic infection (especially in the oral cavity), etc. The purpose of this pare is to determine the effectiveness of the use of the non-steroidal anti-inflammatory drug “Nimesil” in the complex treatment of acute arthritis of the TMJ. We observed 64 patients in age from 24 to 65 years who were diagnosed with acute post-traumatic arthritis of the TMJ. Patients were divided into 2 observation groups: 1st group (the main one) – 31 patients who were treated with the nonsteroidal anti-inflammatory drug “Nimesil” and 2nd group (the control one) – 33 patients who were prescribed treatment, including the use of a nonsteroidal anti-inflammatory drug “Indomethacin.” The duration of the treatment was 7-8 days. After the relieving of acute inflammation, according to indications, prosthetic treatment was carried out. Treatment was carried out in 64 patients with acute post-traumatic arthritis of the temporomandibular joints by comparative use of various non-steroidal anti-inflammatory drugs in different observation groups. It has been proved that the drug “Nimesil” has a more expressed analgesic, antiinflammatory and antipyretic effect, and also has a significantly smaller number of side effects compared to the drug “Indomethacin.”

Obstructive Submandibular Sialadenitis Complicated with Severe Neck Phlegmon: Transcutaneous Removal of Sialolith with a Flow of Pus: Literature Review of Extraoral Complications

Sialolithiasis, as the most common reason (60–85 percent) of obstructive salivary gland disease, in the rare cases, may be complicated by soft tissues abscess or/and fistula. The purpose of this report is to present a rare case of submandibular gland sialolithiasis complicated with severe neck phlegmon in a 47-year-old Caucasian male. Ultrasonography and transcutaneous removal of sialolith upon the purulent locus lancing are highlighted. Our literature review based on the existed ones with a total 24 complication cases is presented. Wakoh et al`s classification of submandibular gland sialolith-associated fistulas types is analyzed. The ultrasound imaging is still underestimated and not adequately popularized among head and neck and oral and maxillofacial surgeons. Presented case and published reports show the usefulness of this constantly developing diagnostic technique in a combination with knowledge of possible extraoral purulent complications’ and its management.

Prevention of Complications Arising after Tooth Extraction

The study involved 67 patients with acute odontogenic inflammatory diseases of the jaws were examined. All examined patients underwent tooth extraction, which caused the development of an acute inflammatory process. We have determined the effectiveness of treatment of patients with the drug “Givalex,” which was used to prevent inflammatory post-extraction complications in patients with acute odontogenic inflammatory diseases. Based on the examinations of patients, it was proved that the multicomponent preparation “Givalex” used for oral baths after tooth extractions has an expressed antiseptic, anti-inflammatory and analgesic effect, as well as a deodorizing effect.

Ukraine: Legal Forms for Private Practice in Oral Surgery and Dentistry

During the last 30 years of Ukrainian independence the private dental businesses are flourishing what is a very good sign not only for patients and dental professionals, but also for economy. As of January 1, 2019, 4,584 privately owned dental institutions were registered Ukraine. Among them, 669 were dental clinics and 3,915 – dental offices.1 Generally, dental care in Ukraine (as of January 1, 2019) was provided by 25,651 dentists of six specialties.1 According to these 2019 data, we can hypostatize that every sixth dentist in Ukraine is an owner of a private clinic/office.1 Moreover, as of January 1, 2021, the number of private dental practices for the first time in history of this country increased to 5,084 (ie, showed a 8.72 percent growth during a 2019 to 2021 period).

Opening New Markets for Your Private Practice Business and Manufacturing in Oral Surgery Needs

A little competition is a good thing and severe competition is a blessing. Thank God for competition. —Jacob Kindleberger Germany-borned United States mill owner Oral surgery and dentistry are highly competitive fields. Competition among private practices in Ukraine is intensifying. Moreover, according to the 2016 data, 3,734 private dental/stomatological clinics (offices) were registered in this country.1,2 And this despite the fact that the first private clinics in modern Ukraine start to appear only in 1991, the year of independence after the collapse of the Soviet Union. That is, we can assume that the market of private clinics for 25 years in Ukraine has grown by phenomenal 3,734 percent. At the same time, there is a tendency towards a decrease in the number of state stomatological policlinics what is also a part of the field`s evolution.1,2 The interesting thing we should understand is that some of private clinics and their owners can compete not only in the treatment process, but also as manufacturers and sellers of the products for dentistry/oral surgery. Previously, only a CE marking (CE abbreviation of Conformité Européenne [in French] mean European Conformity) and a dealer's office were required to operate in the EU market, but now, due to the reformatting of the legislation, it is necessary to have an authorized representative. Such companies` sectors as U-Represent3 can help Ukrainian manufacturers in uncomplicated and inexpensive way to reach European Union and Switzerland markets. The services of U-Represent are: 1) Pre-audit document review, 2) conformation of documents, 3) archive and storage location, 4) products registration in European database on medical devices (EUDAMED), 5) post-market surveillance monitoring, etc.3 Thus, with authorized representatives, who are doctors with PhD and certified ISO (ie, the International Organization for Standardization) professionals, your dental business and manufacturing can hold a strong position not only on domestic market but also to take a share in the growing European and Switzerland marketplaces.

Influence of the Neural Crest Derived Stem Cells to Optic Nerve Regeneration After Its Experimental Injury

Purpose: Orbital trauma is a challenging problem due to such severe sequel as diplopia, decrease of vision or eye motility disorder. However, the conditions of orbital soft tissue content still become underestimated. The aim of this study was to investigate structural changes in the rat optic nerve after experimental injury followed by treatment with stem cells. Materials and Ьethods: An experimental model of injury to the orbital soft tissue content in the rat was developed. Forty Wistar rats maintained under daylight were divided into two equal experimental groups. Unlike the rats of Group I, in rats of Group II, the site of injury to the orbital soft tissue mass received postnatal multipotent stem cells, epidermal neural crest stem cells (NCSCs) derived from the bulge of hair follicles. Results: Comparing the number of glial cells per certain area of the slice (NC) between group І and site without injury (control) after 3 week of observation, it was higher in group I more than 258.8% (p < 0.0001) and on 272.4% in group II (p < 0.0001). After 6 weeks NC in group I was higher than at previous terms: more then 128.9% (р < 0.0001). At the same, NC in group II was higher comparing with previous terms only on 17.1% (р = 0.0212). Between the animals of group I at terms of 12 and 24 weeks NC high and wasn’t significantly differ between this terms of observation (ANOVA p = 0.4379). In contrast, NC in group II stopped rising between 6 and 12 weeks demonstrating statistical equality (p = 0.4563). Conclusions: It can be assumed that the application of mesenchymal stem cells, derivates of the neural crest, after the experimental orbital trauma, stimulates a recovery of the optic nerve. Further studies should be performed to more deeply discover the neural crest derived stem cell populations, ivoleved into recovery of damaged optic nerves.